SCHEMBL21716669

SCHEMBL21716669

CCN(CCN(C)C)C(=O)CNCc1cc(C(=O)Nc2c(OC(C)C)cccc2OC(C)C)ccn1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 14/20 0.67
KDM5C P41229 8/20 0.67
KDM5A P29375 7/20 0.67
KDM4A O75164 2/20 0.63
KDM6B O15054 1/20 0.63
KDM2B Q8NHM5 1/20 0.63
KDM4C Q9H3R0 2/20 0.62
KDM5D Q9BY66 1/20 0.62
MEN1 O00255 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ACKR3 P25106 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21716659 0.97 KDM5B (0.64) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL21716665 0.90 KDM5B (0.68) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL21717749 0.88 KDM5B (0.56) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL16291539 0.86 KDM5B (0.77) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL26862778 0.86 KDM5B (0.49) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL21716662 0.85 KDM5B (0.84) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL26862781 0.83 KDM5B (0.46) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL15637608 0.82 KDM5B (0.74) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL21716663 0.80 KDM5B (1.00) KDM5BKDM5CKDM5AKDM4AKDM6B
SCHEMBL26862742 0.79 KDM5B (0.71) KDM5BKDM5CKDM5AKDM4AKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382865-A1 HISTONE DEMETHYLASE 5 INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-11-30 US disclosed
WO-2020033377-A1 HISTONE DEMETHYLASE 5 INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2020-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382865-A1 HISTONE DEMETHYLASE 5 INHIBITORS AND USES THEREOF KDM5A, KDM5B, KDM5C KDM5B 2/4885KDM5C 3/4885KDM5A 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.